Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.

Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW. · 2010

Read Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. by Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3113287.txt.

Description

The Endogenous Hormones and Breast Cancer Collaborative Group pooled data from seventeen long-term studies for a 2010 report in The Lancet Oncology. They studied a growth factor in blood that drives cell division and blocks cell death, asking whether higher levels predict breast cancer. Records covered thousands of women who later developed the disease and matched controls in twelve countries.

Women in the highest fifth for the growth factor had a notably higher risk of breast cancer than women in the lowest fifth. Adjusting for its main binding protein did not change the result, and the link held before and after menopause. The raised risk appeared only for tumours that respond to the hormone oestrogen. The study gives one of the firmest estimates of this hormone-related risk.

Catalog record

CREATOREndogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3113287

Browse the full library · About the Tower of Babel